ETrade Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-25,115
Closed -$1.11M 769
2017
Q4
$1.11M Buy
25,115
+124
+0.5% +$5.65K 0.04% 322
2017
Q3
$1.25M Buy
24,991
+8,460
+51% +$432K 0.04% 264
2017
Q2
$873K Buy
+16,531
New +$886K 0.03% 313
2016
Q3
Sell
-19,114
Closed -$1.06M 554
2016
Q2
$1.06M Sell
19,114
-641
-3% -$35.3K 0.06% 204
2016
Q1
$1.05M Buy
+19,755
New +$973K 0.06% 191
2014
Q2
Sell
-3,896
Closed -$106K 622
2014
Q1
$106K Sell
3,896
-607
-13% -$18K 0.01% 468
2013
Q4
$161K Sell
4,503
-384
-8% -$12.8K 0.01% 307
2013
Q3
$147K Sell
4,887
-387
-7% -$12.7K 0.01% 297
2013
Q2
$154K Buy
+5,274
New +$149K 0.02% 268

Other funds holding PBH

ETrade Capital Management's PBH Position: Q1 2018 in Review

ETrade Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q1 2018, closing a stake of 25,115 shares — an estimated $1.11M sold.

ETrade Capital Management first reported a position in PBH in Q2 2013 and held it in 9 quarters. The position peaked at $1.25M in Q3 2017. 239 funds tracked by Wall St. Rank hold PBH as of Q1 2018.

  • ETrade Capital Management reported no remaining Prestige Consumer Healthcare position as of Q1 2018 after selling out during the quarter.
  • ETrade Capital Management sold 25,115 Prestige Consumer Healthcare shares in Q1 2018, an estimated $1.11M.
  • ETrade Capital Management first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 9 quarters.
  • ETrade Capital Management's Prestige Consumer Healthcare position peaked at $1.25M in Q3 2017.
  • 239 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2018.

Based on ETrade Capital Management's 13F filing for Q1 2018, filed 7 May 2018.